Evidence map›Paper›PMID 38183119›Full record

ArticleMicrobial cell factories2024

Systematic engineering enables efficient biosynthesis of L-phenylalanine in E. coli from inexpensive aromatic precursors.

Mengzhen Nie, Jingyu Wang, Zeyao Chen, Chenkai Cao, Kechun Zhang

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mengzhen NieZhejiang University, Hangzhou, 310027, Zhejiang, China.
Jingyu WangCenter of Synthetic Biology and Integrated Bioengineering, School of Engineering, Westlake University, Hangzhou, 310030, Zhejiang, China.
Zeyao ChenZhejiang University, Hangzhou, 310027, Zhejiang, China.
Chenkai CaoZhejiang University, Hangzhou, 310027, Zhejiang, China.
Kechun ZhangCenter of Synthetic Biology and Integrated Bioengineering, School of Engineering, Westlake University, Hangzhou, 310030, Zhejiang, China. zhangkechun@westlake.edu.cn.
Westlake University · CNZhejiang University · CN

Funding

the National Natural Science Foundation of China 10327A012001
6 · The paper itself

Abstract

backgroundL-phenylalanine is an essential amino acid with various promising applications. The microbial pathway for L-phenylalanine synthesis from glucose in wild strains involves lengthy steps and stringent feedback regulation that limits the production yield. It is attractive to find other candidates, which could be used to establish a succinct and cost-effective pathway for L-phenylalanine production. Here, we developed an artificial bioconversion process to synthesize L-phenylalanine from inexpensive aromatic precursors (benzaldehyde or benzyl alcohol). In particular, this work opens the possibility of L-phenylalanine production from benzyl alcohol in a cofactor self-sufficient system without any addition of reductant.

resultsThe engineered L-phenylalanine biosynthesis pathway comprises two modules: in the first module, aromatic precursors and glycine were converted into phenylpyruvate, the key precursor for L-phenylalanine. The highly active enzyme combination was natural threonine aldolase LtaE

conclusionSystematical bioconversion processes have been designed and constructed, which could provide a potential bio-based strategy for the production of high-value L-phenylalanine from low-cost starting materials aromatic precursors.

Indexed as

BenzaldehydesPhenylalanineBenzyl AlcoholEscherichia coliPhenylpyruvic AcidsReducing AgentsbenzaldehydeBenzaldehydesBenzyl AlcoholPhenylalaninephenylpyruvic acidPhenylpyruvic AcidsReducing AgentsAromatic precursorsBenzaldehydeBenzyl alcoholEngineeringEscherichia coliL-phenylalanine

Identifiers

PMID38183119
PMCPMC10768146
OpenAlexW4390609883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.